Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics

Detalhes bibliográficos
Autor(a) principal: Pimpão, Catarina Gonçalves
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/86723
Resumo: Aquaporins (AQPs) are transmembrane proteins that facilitate the diffusion of water and glycerol across cell membranes, crucial for water and energy homeostasis. These proteins were found overexpressed in different cancer cells and tissues, being involved in tumor formation, cell proliferation and migration, suggesting their great potential as drug targets for cancer treatment. Identification of novel aquaporin modulators to be used in cancer therapeutics is of utmost importance. In this study, the inhibitory effect of polyoxometalates, vanadium, copper, zinc and gold-based compounds was screened by the stopped-flow technique in human red blood cells (RBCs) and then validated in aquaporin-expressing yeast cells. From the set of polyoxometalates, polyoxotungstate-A (POT-A) revealed as the most promising AQP3 inhibitor with an IC50 of (0.71 ± 0.04) μM. Using yeast cells individually expressing human aquaporins, POT-A showed to selectively inhibit AQP3 with 100% inhibition, corroborating the results of RBCs assays. The vanadium compound P103, showed highly inhibition of AQP1 with an IC50 of (9.11 ± 0.03) μM in RBCs. The gold-based compound RBA29 revealed as a promising AQP3 inhibitor with an IC50 of (2.29 ± 0.03) μM in RBCs. Moreover, compounds RBA29, RBA31 and STAM013 showed an inhibitory effect in AQP9-tranformed yeasts, with an IC50 of (6.64 ± 0.09) μM for RBA29. In addition, investigation of the channel residues important for AQP5 permeability revealed a new gating mechanism where His73 located in the selectivity filter interacts with phosphorylated Ser183, conducting to the pore constriction. Furthermore, the activity of aquaporins from diverse organisms was evaluated, wherein aquaporin from tardigrade revealed to be water selective and exhibited higher water permeability than the other aquaporins tested. Overall, these data contribute to the discovery and design of selective inhibitors with potential therapeutic application.
id RCAP_5a4956b4c0abdcfb67d6770e6bda2e45
oai_identifier_str oai:run.unl.pt:10362/86723
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Screening and Validation of Aquaporin Inhibitors for Cancer TherapeuticsaquaporinspermeabilityinhibitorscancerDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaAquaporins (AQPs) are transmembrane proteins that facilitate the diffusion of water and glycerol across cell membranes, crucial for water and energy homeostasis. These proteins were found overexpressed in different cancer cells and tissues, being involved in tumor formation, cell proliferation and migration, suggesting their great potential as drug targets for cancer treatment. Identification of novel aquaporin modulators to be used in cancer therapeutics is of utmost importance. In this study, the inhibitory effect of polyoxometalates, vanadium, copper, zinc and gold-based compounds was screened by the stopped-flow technique in human red blood cells (RBCs) and then validated in aquaporin-expressing yeast cells. From the set of polyoxometalates, polyoxotungstate-A (POT-A) revealed as the most promising AQP3 inhibitor with an IC50 of (0.71 ± 0.04) μM. Using yeast cells individually expressing human aquaporins, POT-A showed to selectively inhibit AQP3 with 100% inhibition, corroborating the results of RBCs assays. The vanadium compound P103, showed highly inhibition of AQP1 with an IC50 of (9.11 ± 0.03) μM in RBCs. The gold-based compound RBA29 revealed as a promising AQP3 inhibitor with an IC50 of (2.29 ± 0.03) μM in RBCs. Moreover, compounds RBA29, RBA31 and STAM013 showed an inhibitory effect in AQP9-tranformed yeasts, with an IC50 of (6.64 ± 0.09) μM for RBA29. In addition, investigation of the channel residues important for AQP5 permeability revealed a new gating mechanism where His73 located in the selectivity filter interacts with phosphorylated Ser183, conducting to the pore constriction. Furthermore, the activity of aquaporins from diverse organisms was evaluated, wherein aquaporin from tardigrade revealed to be water selective and exhibited higher water permeability than the other aquaporins tested. Overall, these data contribute to the discovery and design of selective inhibitors with potential therapeutic application.Soveral, GraçaRUNPimpão, Catarina Gonçalves2019-11-08T16:06:41Z2019-1020192019-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/86723enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:38:52Zoai:run.unl.pt:10362/86723Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:36:42.988010Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
title Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
spellingShingle Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
Pimpão, Catarina Gonçalves
aquaporins
permeability
inhibitors
cancer
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
title_short Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
title_full Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
title_fullStr Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
title_full_unstemmed Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
title_sort Screening and Validation of Aquaporin Inhibitors for Cancer Therapeutics
author Pimpão, Catarina Gonçalves
author_facet Pimpão, Catarina Gonçalves
author_role author
dc.contributor.none.fl_str_mv Soveral, Graça
RUN
dc.contributor.author.fl_str_mv Pimpão, Catarina Gonçalves
dc.subject.por.fl_str_mv aquaporins
permeability
inhibitors
cancer
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
topic aquaporins
permeability
inhibitors
cancer
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
description Aquaporins (AQPs) are transmembrane proteins that facilitate the diffusion of water and glycerol across cell membranes, crucial for water and energy homeostasis. These proteins were found overexpressed in different cancer cells and tissues, being involved in tumor formation, cell proliferation and migration, suggesting their great potential as drug targets for cancer treatment. Identification of novel aquaporin modulators to be used in cancer therapeutics is of utmost importance. In this study, the inhibitory effect of polyoxometalates, vanadium, copper, zinc and gold-based compounds was screened by the stopped-flow technique in human red blood cells (RBCs) and then validated in aquaporin-expressing yeast cells. From the set of polyoxometalates, polyoxotungstate-A (POT-A) revealed as the most promising AQP3 inhibitor with an IC50 of (0.71 ± 0.04) μM. Using yeast cells individually expressing human aquaporins, POT-A showed to selectively inhibit AQP3 with 100% inhibition, corroborating the results of RBCs assays. The vanadium compound P103, showed highly inhibition of AQP1 with an IC50 of (9.11 ± 0.03) μM in RBCs. The gold-based compound RBA29 revealed as a promising AQP3 inhibitor with an IC50 of (2.29 ± 0.03) μM in RBCs. Moreover, compounds RBA29, RBA31 and STAM013 showed an inhibitory effect in AQP9-tranformed yeasts, with an IC50 of (6.64 ± 0.09) μM for RBA29. In addition, investigation of the channel residues important for AQP5 permeability revealed a new gating mechanism where His73 located in the selectivity filter interacts with phosphorylated Ser183, conducting to the pore constriction. Furthermore, the activity of aquaporins from diverse organisms was evaluated, wherein aquaporin from tardigrade revealed to be water selective and exhibited higher water permeability than the other aquaporins tested. Overall, these data contribute to the discovery and design of selective inhibitors with potential therapeutic application.
publishDate 2019
dc.date.none.fl_str_mv 2019-11-08T16:06:41Z
2019-10
2019
2019-10-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/86723
url http://hdl.handle.net/10362/86723
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137985106542592